QualTek Molecular Laboratories

The founders of QualTek previously founded BioTek Solutions, Inc. in 1989 a company that designed instrumentation and detection systems to automate immunohistochemistry (IHC) and in situ hybridization (ISH) assays. These instruments and reagent systems were sold worldwide primarily to clinical pathology laboratories. BioTek merged with Ventana Medical Systems and the combined company is now publicly traded. Our time at this company not only provided us with a great deal more experience in IHC and ISH assays, but it made it clear to us that there was a need for our expertise in the research community. Thus, QualTek was created in 1996 to provide expert IHC and ISH assays and their detailed analyses to researchers within biotechnology and pharmaceutical companies. QualTek’s scientific staff possesses over 50 years of combined experience in IHC and ISH. The founders are recognized as industry leaders. The company and projects are overseen by Ph.D. level scientists with proven experience in antibody and probe development and optimization and reagent development and manufacturing. QualTek’s scientists have experience in both diagnostic and research applications and strive to reach the highest standards and attain the best results with every project. The “leave no stone unturned” detailed approach that we nurture at QualTek ensures that every sample submitted will yield satisfactory results whenever possible. Finally, QualTek complies with “Good Laboratory Practices” from the beginning to the end of every project to ensure that the project can withstand scientific scrutiny.

Contact Details: 334 South Patterson Ave. Suite 208 Santa Barbara California 93111 United States of America Tel: 805-681-3200 Fax: 805-583-6379 Email: sbernstein@qmlabs.com WWW: www.qmlabs.com/

Loading...

BioNews Results for QualTek Molecular Laboratories:
Microbix gets Canadian nod to market urokinase injection	PharmaBiz:  Nov 12 2009 9:25AM Matching: molecular laboratories
Microbix Biosystems receives Health Canada's marketing and export approval for KINLYTIC	News-Medical.Net:  Nov 11 2009 5:41AM Matching: molecular laboratories
Microbix Receives Approval To Market Thrombolytic Agent Kinlytic (urokinase) In Canada	Pharma Live:  Nov 11 2009 3:14AM Matching: molecular laboratories
Microbix Receives Approval To Market Thrombolytic Agent Kinlytic(TM) (urokinase) In Canada	SmartBrief:  Nov 11 2009 12:46AM Matching: molecular laboratories
Association for Molecular Pathology's 15th Annual Meeting and Exhibits	Research & Development:  Nov 10 2009 12:39AM Matching: molecular laboratories
Promote your company here: BioNewsCast - Press Release Distribution	→View more QualTek Molecular Laboratories news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 557 times since April 2007, the link to the organisation's website has been followed 107 times

Recent Search Terms used to find this page: QualTek Molecular Laboratories | QualTek Molecular Laboratories | QualTek Molecular Laboratories | QualTek Molecular Laboratories | publicly traded medical companies immunohistochemistry | qualtek molecular laboratories | QualTek Molecular Laboratories | molecule labs nasdaq | qualtek molecular laboratories | qualtek | .

Search for more companies in Santa Barbara

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for QualTek Molecular Laboratories